LRRK2 and Parkinson disease: Since aberrant activation of LRRK2 has been reported in idiopathic PD without LRRK2 mutations (Di Maio et al., 2018; Petropoulou-Vathi et al., 2022), the activation of the VAIL pathway may also be involved in the pathogenetic process of PD.